National Academy of Medicine Elects Alliance Group Chair Among 100 New Members
The National Academy of Medicine (NAM) announced the election of 90 regular members and 10 international members during its annual meeting this month, among which included Alliance Group Chair Monica M. Bertagnolli, MD. Election to the Academy is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.
Dr. Bertagnolli is also the Richard E. Wilson MD Professor of Surgery at the Harvard Medical School and an Associate Surgeon at the Dana-Farber/Brigham and Women’s Cancer Center. She was elected as a regular member with the following citation: For numerous leadership roles in multi-institutional cancer clinical research consortia and advancing the quality and scope of research to bring important new treatments to people with cancer.
New members are elected by current members through a process that recognizes individuals who have made major contributions to the advancement of the medical sciences, health care, and public health. The National Academy of Medicine, established in 1970 as the Institute of Medicine, is an independent organization of eminent professionals from diverse fields including health and medicine; the natural, social, and behavioral sciences; and beyond. It serves alongside the National Academy of Sciences and the National Academy of Engineering as an adviser to the nation and the international community. Through its domestic and global initiatives, the NAM works to address critical issues in health, medicine, and related policy and inspire positive action across sectors. The NAM collaborates closely with its peer academies and other divisions within the National Academies of Sciences, Engineering, and Medicine. With their election, NAM members make a commitment to volunteer their service in National Academies activities.
The newly elected members bring NAM’s total membership to more than 2,200 and the number of international members to approximately 172.
Related Posts
Combo Extends OS in Patients 65+ with Ph+ ALL
Long-term results show combination treatment that skips chemotherapy is effective for older patients with Ph+ ALL
Model Predicts AI Non-adherence Risk
A new risk model uses baseline sociodemographic and financial measures to predict which patients prescribed long-term therapy with aromatase inhibitors for breast cancer are at significantly higher risk of stopping that therapy early
ECOG-ACRIN and PrECOG announce multiple presentations at ASH 2023
Researchers with the ECOG-ACRIN Cancer Research Group and PrECOG, LLC will present six oral and three poster presentations at the 65th American Society of Hematology Meeting & Exposition